Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Biocon Group on Tuesday reported a 20% year-on-year increase in operating revenue in the second quarter of FY26 to Rs ...
Tag: Kiran Mazumdar-Shaw
